Home / Departments / Centers & Institutes / Tulane Cancer Center / Research / Office of Clinical Research / Clinical Trials Study Finder / Brain / Brain Clinical Trials
NRG BN007
A Randomized Phase II/III Open Label Study of Ipilimumab and Nivolumab Versus Temeozolomide in Patients With Newly Diagnosed MGMT (Tumor o-6-Methylguanine DNA Methyltransferase) Unmethylated Glioblastoma
More Information